The synthetic biology market is expected to rise from US$ 3.75 billion in 2024 to US$ 31.73 billion by 2034, growing at a lucrative 23.8% CAGR over the forecast period. The rising need to enhance practical capabilities, redesign naturally occurring systems, and develop new biological components, tools, and systems is driving the market forward.
The market for synthetic biology is growing rapidly due to the growing demand for bio-based chemicals, renewable fuels, and affordable medications and vaccines that use artificial biology. The growing need for genetically modified crops to feed the expanding global population drives developments in the synthetic biology market.
Synthetic biology is positioned to be a major player in addressing urgent social and environmental concerns as a result of the confluence of technology advancement and growing market needs, which bodes well for further development and innovation during the forecast period.
Key Market Highlights
| Attributes | Details |
|---|---|
| Synthetic Biology Market Value, 2024 | US$ 3.75 billion |
| Projected Market Value, 2034 | US$ 31.73 billion |
| Value-based CAGR (2024 to 2034) | 23.8% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
This section provides a comprehensive analysis of the market during the last five years, highlighting the expected growth patterns. The market is changing steadily, as seen by its strong historical CAGR of 21.7% from 2019 to 2023. Based on sustained growth at a 23.8% CAGR through 2034, the industry is predicted to expand in the future.
| Historical CAGR | 21.7% |
|---|---|
| Forecast CAGR | 23.8% |
The global synthetic biology market is expected to face growth barriers from ethical issues, regulatory constraints, and public mistrust about safety.
Crucial factors that are anticipated to affect the demand for synthetic biology through 2034.
Market players are anticipated to need to be astute and adaptable during the anticipated period, as these tough aspects position the industry for future development.
Renewability of the Bio-Based Chemicals Fuels the Synthetic Biology Industry
The growing need for bio-based products and sustainable energy is driving tremendous expansion in the synthetic biology sector. Novel biological systems that can economically and sustainably manufacture a variety of molecules, such as industrial chemicals, medicines, and biofuels, have been made possible using artificial biology approaches.
The advancements in genetic engineering, metabolic engineering, and synthetic biology tools have enabled researchers to engineer microorganisms to produce high-value chemicals and fuels from renewable resources such as biomass, algae, and waste materials.
This has opened up new avenues for developing sustainable and eco-friendly products to address the growing concerns of environmental pollution and energy security, propelling the growth of the global synthetic biology industry.
Rising Interest in Cost-Effective Drugs and Vaccines Surging Market Demand
Global interest in synthetic biology has increased due to the growing need for affordable medications and vaccinations. A whole new range of opportunities for drug discovery and precision medicine are made possible by synthetic biology approaches, which provide a distinctive and inventive approach to designing and engineering biological systems.
Modern developments in synthetic cell biology allow researchers to design whole biological systems, alter already-existing ones, or build new physical components to produce unique solutions. The goal of creating safe, efficient, and reasonably priced medications and vaccines for a range of illnesses and ailments has led to a rapid expansion of the global synthetic biology industry.
Synthetic Biology Provides Fertile Ground for Genetically Modified Crops
The increased acceptance of genetically modified crops is driving the demand for synthetic biology products in the global market. The demand for sustainable food supplies has grown urgently due to the rising global population.
One practical way to address this problem is through synthetic biology, which can enhance the crop production process. Scientists and researchers can employ improvements in gene editing technology to make crops more resistant to pests and diseases, have longer shelf lives, and produce larger yields. These benefits drive the adoption of synthetic biology in the agriculture sector and are expected to propel market growth in the coming decade.
Principal Consultant
| Attributes | Details |
|---|---|
| Top Product | Oligonucleotides |
| Market share in (2024) | 43.60% |
The demand for oligonucleotides is anticipated to rule the synthetic biology market, with an advantageous market share of 43.6% in 2024. Several reasons exist for this inclination for oligonucleotides in the global synthetic biology market:
| Attributes | Details |
|---|---|
| Top End User | Biopharmaceutical Manufacturers |
| Market share in 2024 | 43% |
In 2024, biopharmaceutical manufacturing is expected to account for a leading market share of 43%. The following reasons are driving the segment’s growth:
| Countries | CAGR from 2024 to 2034 |
|---|---|
| United Kingdom | 19% |
| China | 26% |
| India | 27% |
| Japan | 12.5% |
| Germany | 14.8% |
The United Kingdom's synthetic biology industry is expected to develop at a staggering CAGR of 19% from 2024 to 2034. The following factors are driving the demand for synthetic biology, which is anticipated to play a crucial role in the growth of the United Kingdom's biopharmaceutical sector:
The German synthetic biology industry is anticipated to acquire a market share of 8% and is projected to demonstrate an impressive CAGR of 14.8% from 2024 to 2034. Some of the primary drivers of the growth of the German synthetic biology sector include:
The Chinese market for synthetic biology is poised to rise at a staggering CAGR of 26% through 2034. Among the main trends in the development of the synthetic biology market in China are:
From 2024 to 2034, the Indian market for synthetic biology is anticipated to grow at a consistent rate of 27% CAGR. The following are some significant patterns illustrating the growth of Indian synthetic biology:
The Japanese synthetic biology market is well-positioned to be a catalyst for pharmaceutical innovation due to its substantial development potential. The market is projected to expand at a 12.5% CAGR from 2024 to 2034, gaining a 5.70% market share. Some of the key developments propelling the market's growth are as follows:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The future and trajectory of the global synthetic biology industry are significantly shaped by market participants through their innovative approaches, collaborative efforts, and strategic investments. These businesses are at the forefront of creating innovative technologies, spearheading R&D initiatives, and bringing synthetic biology solutions to market across various industries.
Organizations such as Agilent Technologies, Inc. and Thermo Fisher Scientific, Inc. constantly push the frontiers of synthetic biology by investing in research and development and creating new instruments, methods, and applications. They use synthetic biology to tackle urgent environmental and societal issues, including customized health, renewable energy generation, and sustainable agriculture.
Establishments such as Medichem and Bota Bio fuel market growth by forming strategic alliances and working with universities, research centers, and other business stakeholders.
These partnerships promote technology transfer, information sharing, and the creation of new synthetic biology goods and services. Corporations proactively collaborate with regulatory bodies to effectively manage the intricate regulatory framework for synthetic biological products.
By guaranteeing compliance and resolving ethical and safety issues, businesses are gaining the faith and confidence of investors, regulators, and consumers in synthetic biology technology.
Market players are driving innovation, accelerating market adoption, and shaping the future of the global synthetic biology industry, positioning it as a key driver of economic growth and technological advancement in the forthcoming decade.
Recent Developments in the Synthetic Biology Industry
The global synthetic biology market is expected to value at US$ 3.75 billion in 2024.
Products such as oligonucleotides, enzymes, synthetic cells, cloning technologies kits, xeno-nucleic acids, and chassis organisms are available in the market.
The synthetic biology market is controlled by the United Kingdom, China, India, Japan, and Germany.
The synthetic biology market is anticipated to surpass US$ 31.73 billion by 2034.
The industry is anticipated to grow at a CAGR of 23.8% from 2024 to 2034.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2024 to 2034
5.3.1. Oligonucleotides
5.3.2. Enzymes
5.3.3. Synthetic Cells
5.3.4. Cloning Technologies Kits
5.3.5. Xeno-Nucleic Acids
5.3.6. Chassis Organism
5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034
6.3.1. Healthcare
6.3.2. Non-Healthcare
6.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2024 to 2034
7.3.1. Biotechnology and Pharmaceutical Companies
7.3.2. Academic and Government Research Institutes
7.3.3. Others
7.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Product
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Product
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Product
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Product
14.2.3. By Application
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Application
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Application
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2023
16.1.2.1. By Product
16.1.2.2. By Application
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2023
16.2.2.1. By Product
16.2.2.2. By Application
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2023
16.3.2.1. By Product
16.3.2.2. By Application
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2023
16.4.2.1. By Product
16.4.2.2. By Application
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2023
16.5.2.1. By Product
16.5.2.2. By Application
16.5.2.3. By End User
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2023
16.6.2.1. By Product
16.6.2.2. By Application
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2023
16.7.2.1. By Product
16.7.2.2. By Application
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2023
16.8.2.1. By Product
16.8.2.2. By Application
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2023
16.9.2.1. By Product
16.9.2.2. By Application
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2023
16.10.2.1. By Product
16.10.2.2. By Application
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2023
16.11.2.1. By Product
16.11.2.2. By Application
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2023
16.12.2.1. By Product
16.12.2.2. By Application
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2023
16.13.2.1. By Product
16.13.2.2. By Application
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2023
16.14.2.1. By Product
16.14.2.2. By Application
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2023
16.15.2.1. By Product
16.15.2.2. By Application
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2023
16.16.2.1. By Product
16.16.2.2. By Application
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2023
16.17.2.1. By Product
16.17.2.2. By Application
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2023
16.18.2.1. By Product
16.18.2.2. By Application
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2023
16.19.2.1. By Product
16.19.2.2. By Application
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2023
16.20.2.1. By Product
16.20.2.2. By Application
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2023
16.21.2.1. By Product
16.21.2.2. By Application
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2023
16.22.2.1. By Product
16.22.2.2. By Application
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2023
16.23.2.1. By Product
16.23.2.2. By Application
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Application
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Thermo Fisher Scientific, Inc.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Merck KGaA
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Novozymes
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Agilent Technologies, Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Codexis, Inc.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Bota Biosciences Inc.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Creative Biogene.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Creative Enzymes.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Enbiotix, Inc.
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Illumina, Inc.
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Eurofins Scientific
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Synthetic Biology Market
